Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Uvlrx Therapeutics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Uvlrx Therapeutics

Uvlrx Therapeutics

Closed

UVLrx Therapeutics: Pioneering safe, effective treatments in healthcare and biotechnology since 2011.

HQ
Santa Barbara, CA, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Founded in 2011 and headquartered in Santa Barbara, California, UVLrx Therapeutics is a biotechnology company dedicated to providing safe and effective therapeutic solutions. The company's core mission is to address some of the medical community’s most challenging ailments through innovative treatments. UVLrx Therapeutics focuses on developing advanced medical and healthcare products that leverage cutting-edge technology to improve patient outcomes.

UVLrx Therapeutics has made significant strides in the biotechnology sector, attracting notable investors and affiliations within the medical community. The company's pioneering efforts have led to key achievements in the development of therapeutic solutions that are both safe and effective. As a result, UVLrx Therapeutics has had a substantial impact on the healthcare industry, contributing to advancements in treatment options and improving the quality of life for patients worldwide.

Uvlrx Therapeutics - Similar Companies

Tulavi Therapeutics logo

Tulavi Therapeutics

tulavi.com

Therapyx logo

Therapyx

therapyxinc.com

XRad Therapeutics logo

XRad Therapeutics

Selva Therapeutics logo

Selva Therapeutics

United Therapeutics logo

United Therapeutics

Valerion Therapeutics logo

Valerion Therapeutics

Cancervax logo

Cancervax

cancervax.com

Balx Holdings logo

Balx Holdings

Convoy Therapeutics logo

Convoy Therapeutics

curative ventures logo

curative ventures

UTR Therapeutics logo

UTR Therapeutics

Adcentrx Therapeutics logo

Adcentrx Therapeutics

adcentrx.com

Elysium Therapeutics logo

Elysium Therapeutics

elysiumrx.com

Visiox logo

Visiox

visioxpharma.com

Evincis Bio logo

Evincis Bio

Uvlrx Therapeutics - Quick Facts

Who are Uvlrx Therapeutics' competitors?

Companies similar to Uvlrx Therapeutics include Tulavi Therapeutics, Therapyx, XRad Therapeutics and Selva Therapeutics.

When was Uvlrx Therapeutics founded?

Uvlrx Therapeutics was founded in 2011.

Where is Uvlrx Therapeutics' headquarters located?

Uvlrx Therapeutics' headquarters is located in Santa Barbara, CA, US.

When was Uvlrx Therapeutics' last funding round?

Uvlrx Therapeutics' most recent funding round was for $206k (USD) in November 2016.

How much has Uvlrx Therapeutics raised to-date?

As of Nov 3, 2016, Uvlrx Therapeutics has raised a total of $1.1M (USD).

Uvlrx Therapeutics - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Americas
Main Product
  • Biotech
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research